4th Report - An acceptable risk? The use of Lariam by military personnel
- HC No.
- HC 567
- Published
- 24 May 2016
- Items
- 0
- Government response
- Government response published 13 September 2016. Read the government's response ↗
Select committee: Defence Committee
Lariam inquiry
Closed
Opened 13 Oct 2015
Closed 13 Sep 2016
Defence Committee Inquiry on parliament.uk ↗
Inquiry scope (the committee's words)
Government response published Special Report: An acceptable risk? The use of Lariam for military personnel: Government Response to the Committee's Fourth Report Session 2015–16 Special Report: An acceptable risk? The use of Lariam for military personnel: Government Response to the Committee's Fourth Report Session 2015–16 (PDF 176KB) The Defence Committee's inquiry into the use of Lariam/Mefloquine in the UK Armed Forces.
Where it stands
The inquiry is closed, opened 13 October 2015.
The committee has published 1 report, most recently 4th Report - An acceptable risk? The use of Lariam by military personnel on 24 May 2016.
The government's response
Published 13 September 2016.
Summary written by Accountability Index from the government's response. It is not the government's own words.The government states that the MoD will address the Committee's recommendations through a revised malaria prevention policy, while maintaining that mefloquine (Lariam) continues to be recommended by Public Health England and the World Health Organisation as safe and effective.
- On risk assessments, the revised policy "will direct that all anti-malaria drugs are only supplied after a face-to-face travel health risk assessment". Where this is "physically not possible", a trained Medical Assistant or Medical Technician will carry it out.
- On the call for an audit of Lariam prescriptions since 2013, the government says a retrospective audit "is neither straightforward nor practicable". It will instead undertake a prospective audit of returning travellers "once the revised policy is approved".
- On the Committee's view that Lariam is incompatible with operational duties, the MoD "acknowledges and respects" that opinion but says it is "not aware of any peer-reviewed evidence" that any ACMP-recommended anti-malarial is incompatible with those duties.
- On a single point of contact, work is "in hand to recruit" a team, which it is "anticipated" will be manned by 1 September 2016, with contact details to be publicised widely.
Reports
All reportsEvidence
- 3 oral evidence sessionsLatest 12 January 2016
Recent activity
- 3rd Special Report - An acceptable risk? The use of Lariam for military personnel: Government Response to the Committee’s Fourth Report of Session 2015–1613 September 2016, Report published
- 4th Report - An acceptable risk? The use of Lariam by military personnel24 May 2016, Report published
- Oral evidence session12 January 2016, Oral evidence
Reports
Oral evidence sessions
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
Correspondence
On smaller screens, scroll horizontally to read every column. Keyboard users can focus the table region and use the arrow keys.
| Published | Direction | Letter |
|---|---|---|
| 14 Oct 2015 | Not recorded | Response, 21 September 2015, from the Secretary of State, concerning the use of Lariam in UK Armed Forces |
| 14 Oct 2015 | Not recorded | Letter, 8 September 2015, to Rt Hon Michael Fallon MP, Secretary of State for Defence concerning the use of Lariam by UK Armed Forces |